Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates

This publication has 27 references indexed in Scilit:

• Antimicrobial activity and spectrum of SCH27899 (ziracin®) tested against gram-positive species including recommendations for routine susceptibility testing methods and quality control
  Diagnostic Microbiology and Infectious Disease, 1999
• Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds
  Diagnostic Microbiology and Infectious Disease, 1999
• Prevalence of Antimicrobial Resistance Among Respiratory Tract Isolates ofStreptococcus pneumoniaein North America: 1997 Results from the SENTRY Antimicrobial Surveillance Program
  Clinical Infectious Diseases, 1998
• Antimicrobial Activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) Tested against Over 28,000 Recent Clinical Isolates from 200 Medical Centers in the United States and Canada
  Diagnostic Microbiology and Infectious Disease, 1998
• Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
  Journal of Antimicrobial Chemotherapy, 1997
• Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO antimicrobial activity studied against gram-positive species
  Diagnostic Microbiology and Infectious Disease, 1996
• In-vitro activity of two glycylcyclines against enterococci resistant to other agents
  Journal of Antimicrobial Chemotherapy, 1995
• N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci
  Antimicrobial Agents and Chemotherapy, 1994
• In vitro activities of two glycylcyclines against gram-positive bacteria
  Antimicrobial Agents and Chemotherapy, 1994
• Tetracyclines, molecular and clinical aspects
  Journal of Antimicrobial Chemotherapy, 1992